An Observational Post-Marketing Safety Registry Of Patients Who Have Been Prescribed Sativex

Trial Profile

An Observational Post-Marketing Safety Registry Of Patients Who Have Been Prescribed Sativex

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Cancer pain; Diabetic neuropathies; Multiple sclerosis; Muscle spasticity; Neuropathic pain
  • Focus Adverse reactions
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 10 Oct 2017 Status changed from recruiting to completed.
    • 10 Oct 2015 Final results of patients from the United Kingdom (n=941) presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
    • 05 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top